Intensive Versus Standard Follow up to Improve Continuous Positive Airway Pressure (CPAP) Compliance

December 20, 2013 updated by: Izolde Bouloukaki, University of Crete

Intensive Versus Standard Follow up to Improve Continuous Positive Airway Pressure Compliance: The Greek Experience

The purpose of this study was to compare the effects on sleepiness, quality of life, depression, hospitalization and deaths rate, of intensive vs standard interventions, on CPAP adherence, 2 years after CPAP initiation.

Study Overview

Status

Completed

Conditions

Detailed Description

There is limited data concerning long-term randomized clinical trials proving the long-term efficacy of intensive use, follow programs on improving CPAP use. Therefore the investigators aimed to compare the effects on sleepiness, quality of life, depression, hospitalization and deaths rate, of intensive vs standard interventions, on CPAP adherence, 2 years after CPAP initiation.

Study Type

Interventional

Enrollment (Actual)

2836

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • newly diagnosed obstructive sleep apnea syndrome by polysomnography according to standard criteria,
  • with moderate to severe sleep apnea,
  • no history of previously CPAP therapy and
  • with an above-elementary school education.

Exclusion Criteria:

  • refusal to participate,
  • refusal to CPAP therapy,
  • previous CPAP treatment,
  • central sleep apnoea syndrome,
  • Cheyne-stokes breathing pattern,
  • obesity hypoventilation syndrome,
  • restrictive ventilator syndromes,
  • congestive heart failure,
  • history of life-threatening arrhythmias,
  • cardiomyopathy,
  • long term oxygen therapy,
  • family or personal history of mental illness,
  • with drug or alcohol abuse,
  • severe cognitive impairment,
  • concurrent oncologic diseases and
  • history of narcolepsy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Care
24 hour consultation telephone line to the sleep nurses will be open for the patients. Patients were reviewed at 1 month and at 3 month intervals during the first year and every 6 months thereafter in the CPAP clinic. Additional visits or phone calls by sleep specialist if doubts about a patient's compliance or willingness to continue with the therapy
24-h consultation telephone line to the sleep nurses to answer questions regarding CPAP usage. Patients were reviewed at 1 month and at 3 month intervals during the first year and every 6 months thereafter in the CPAP clinic by the nurse. Additional visits or phone calls by sleep specialist if doubts about a patient's compliance or willingness to continue with the therapy.
Active Comparator: Intensive care

Standard group care plus:

Involvement of the patient's partner or family. Extra education on sleep apnea syndrome and CPAP by sleep specialists via a 15-min videotape. 10- to 15-min lecture from the sleep clinic's nurses. Phone calls by nurses at 2 and 7 days. Early review of patients by sleep specialists at 15 and 30 days. Home visits by sleep nurses, if there doubts about a patients adherence.

Standard group care plus: Involvement of the patient's partner or family necessary. Extra education on sleep apnea and CPAP by sleep specialists via a 15-min videotape. 10- to 15-min lecture from the sleep clinic's nurses after CPAP titration study. Phone calls by nurses at 2 and 7 days. Early review of patients by sleep specialists at 15 and 30 days. Home visits by sleep nurses, if there doubts about a patients adherence

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Effect of intensive intervention on CPAP adherence
Time Frame: 24 months
24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Effect of intensive intervention on sleepiness.
Time Frame: 24 months
24 months
Effect of intensive intervention on mood.
Time Frame: 24 months
24 months
Effect of intensive intervention on quality of life
Time Frame: 24 months
24 months

Other Outcome Measures

Outcome Measure
Time Frame
Effect of intensive intervention on hospitalization rate.
Time Frame: 24 months
24 months
Effect of intensive intervention on withdrawal of CPAP
Time Frame: 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Charalampos Mermigkis, MD, PhD, Sleep Disorders Center, Pulmonary Department, 401 General Army Hospital, Athens, Greece

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

October 1, 2013

Study Registration Dates

First Submitted

November 27, 2013

First Submitted That Met QC Criteria

December 13, 2013

First Posted (Estimate)

December 20, 2013

Study Record Updates

Last Update Posted (Estimate)

December 23, 2013

Last Update Submitted That Met QC Criteria

December 20, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea

Clinical Trials on Standard care

Subscribe